データなし
データなし
Press Release: Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
First Mpox Case Linked to African Outbreak Reported in U.K.
WHO Expands Emergency Use List For Mpox Diagnostics, Adds Cepheid's Xpert Mpox PCR Test And Roche's Cobas MPXV Assay As PCR-Based Gold Standard Options
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024
Reported Earlier, 'New Mpox Variant Detected In Germany: Health Authority' - The Economic Times
Zacks.com Featured Highlights Include Grupo Supervielle, Emergent BioSolutions and Innodata
データなし
データなし